ATI Physical Therapy, Inc.
ATIP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | -0.00 |
| FCF Yield | -314.89% | -116.99% | -151.15% | -14.96% |
| EV / EBITDA | 324.15 | 21.14 | -1.91 | -1.91 |
| Quality | ||||
| ROIC | 0.29% | -3.19% | -4.89% | -1.92% |
| Gross Margin | 13.74% | 13.85% | 11.82% | 17.59% |
| Cash Conversion Ratio | 0.35 | 0.18 | 0.13 | 0.05 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.81% | 3.64% | 2.39% | -7.19% |
| Free Cash Flow Growth | -14.58% | 68.30% | -11.40% | -172.18% |
| Safety | ||||
| Net Debt / EBITDA | 319.41 | 20.42 | -1.75 | -1.13 |
| Interest Coverage | 0.04 | -0.45 | -1.25 | -0.57 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 27.64 | 55.62 |
| Cash Conversion Cycle | 39.72 | 49.83 | 51.89 | 43.81 |